e-learning
resources
Paris 2018
Sunday, 16.09.2018
Pulmonary drug delivery: inhaler use, devices and technologies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Differences in inhaler misuse between patients with asthma and COPD.
M. Miszczuk (Warsaw , Poland), M. Dabrowska (Warsaw , Poland), I. Domagala (Warsaw , Poland), K. Luczak (Warsaw , Poland), M. Maskey-Warzechowska (Warsaw , Poland), R. Krenke (Warsaw , Poland)
Source:
International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Session:
Pulmonary drug delivery: inhaler use, devices and technologies
Session type:
Thematic Poster
Number:
1010
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Miszczuk (Warsaw , Poland), M. Dabrowska (Warsaw , Poland), I. Domagala (Warsaw , Poland), K. Luczak (Warsaw , Poland), M. Maskey-Warzechowska (Warsaw , Poland), R. Krenke (Warsaw , Poland). Differences in inhaler misuse between patients with asthma and COPD.. 1010
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The effect of inhaler switching on asthma and COPD patients
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018
Difference between asthma and COPD patients in adherence and non-adherence patterns to inhaler devices
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Hair analysis to detect chronic inhaler drug use in asthma or COPD patients
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017
COPD: Are beliefs about inhaled medication associated with patients’ inhaler technique?
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018
Description of the UK’s asthma and COPD inhaler use
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018
A digital inhaler uncovering patterns of SABA use in asthma and COPD
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020
Are COPD patients taking triple combination inhalers being overmedicated during acute exacerbations?
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
Bronchodilator reversibility is associated with non-adherence to inhalers in stable asthma patients, without airflow limitation.
Source: Virtual Congress 2020 – Lung function diagnostics
Year: 2020
The effects of different inhaler devices on asthma control in patients with persistent asthma in Turkey
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012
Inhaled medication use in asthma and COPD Roma/Gypsies patients
Source: Eur Respir J 2005; 26: Suppl. 49, 610s
Year: 2005
Comparison of inhaler device preference of the physicians in the treatment of newly diagnosed adult asthma and COPD patients
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019
Preferences for current inhaler devices in patients with asthma
Source: International Congress 2018 – Asthma and drugs
Year: 2018
Determinants of incorrect inhalation technique in patients with asthma and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 69s
Year: 2001
Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020
Inhaler preferences and satisfaction of asthma and COPD patients
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018
The economic impact recurrent inhaler versus single instructions in asthma and COPD patients
Source: Virtual Congress 2021 – Difficult decisions on expected outcomes: availability of hospital resources and improvement of treatment adherence
Year: 2021
Investigating inhaler technique in patients with COPD using different aids
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019
Comparison of inhaler and nebuliser bronchodilator treatments in COPD attacks
Source: Eur Respir J 2002; 20: Suppl. 38, 244s
Year: 2002
Comparing objective inhaler use among COPD and Asthma populations
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept